Pharma and Biotech
Execution of Agreement for North America | 21-Oct-2024 | 07:00 | RNS |
Update on Licensing and Partnership Agreement | 03-Oct-2024 | 13:12 | RNS |
Interim Results | 30-Sep-2024 | 07:00 | RNS |
Holding(s) in Company | 16-Sep-2024 | 07:00 | RNS |
Collaboration with Moffitt Cancer Center | 09-Sep-2024 | 07:00 | RNS |
Update on Strategic Partnership in North America | 25-Jul-2024 | 07:00 | RNS |
Manufacturing Agreement with BBI Solutions | 18-Jul-2024 | 07:00 | RNS |
Issue of Share Options in Lieu of Consultancy Fees | 09-Jul-2024 | 07:00 | RNS |
Result of AGM | 24-Jun-2024 | 12:42 | RNS |
Update on North American Strategic Licensing MoU | 17-Jun-2024 | 07:00 | RNS |
Notice of Annual General Meeting | 03-Jun-2024 | 07:00 | RNS |
Holding(s) in Company | 13-May-2024 | 07:00 | RNS |
Total Voting Rights | 30-Apr-2024 | 17:00 | RNS |
Final results for the year ended 31 December 2023 | 30-Apr-2024 | 09:12 | RNS |
Holding(s) in Company | 23-Apr-2024 | 11:20 | RNS |
Currency | UK Pounds |
Share Price | 1.90p |
Change Today | 0.20p |
% Change | 11.76 % |
52 Week High | 2.60p |
52 Week Low | 1.45p |
Volume | 910,240 |
Shares Issued | 396.39m |
Market Cap | £7.53m |
Beta | 0.75 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:38 | 22,678 @ 1.83p |
13:43 | 6,000 @ 1.83p |
13:16 | 10,000 @ 1.99p |
11:54 | 265,198 @ 1.87p |
10:49 | 10,000 @ 1.88p |
Finance Director | Nigel Ronald Lee |
You are here: research